Literature DB >> 1895264

Rheumatoid factor, cryoglobulinemia, anti-DNA, and renal disease in patients with systemic lupus erythematosus.

T W Howard1, M J Iannini, J J Burge, J S Davis.   

Abstract

We retrospectively analyzed the relationship between rheumatoid factor (RF) and renal disease in 102 patients with systemic lupus erythematosus (SLE). We found a significant negative association between detectable RF at any time in a patient's course and clinically significant renal diseases. Multivariate analysis indicates that RF and cryoglobulins, operating independently, have a significant and opposite association with the development of renal disease in patients with SLE. These associations appear to be unrelated to the presence or absence of anti-ds-DNA (anti-DNA). Patients with SLE who are RF negative and cryoglobulin positive are likely to develop renal disease whereas those who are RF positive and cryoglobulin negative are very unlikely to do so. The addition of RF and cryoglobulin determinations to the data base of patients with SLE appears to be clinically useful.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1895264

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  Rheumatoid factor in patients with systemic lupus erythematosus.

Authors:  A Zoli; L Altomonte; R Caricchio; A Galossi; L Mirone; F Scuderi; M Magaro
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

2.  Rheumatoid factor false positivity in patients with ANCA-associated vasculitis not having medical conditions producing rheumatoid factor.

Authors:  Jae-Seung Moon; Diane Da-Hyun Lee; Yong-Beom Park; Sang-Won Lee
Journal:  Clin Rheumatol       Date:  2017-11-08       Impact factor: 2.980

3.  Factors Associated With Renal Involvement in Primary Sjögren's Syndrome: A Meta-Analysis.

Authors:  Ruping Hong; Dong Xu; Evelyn Hsieh; Yirong Xiang; Jiuliang Zhao; Qian Wang; Xinping Tian; Mengtao Li; Yan Zhao; Xiaofeng Zeng
Journal:  Front Med (Lausanne)       Date:  2020-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.